http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
UPDATE – Surveyed Physicians Say Access Challenges Impact Their Care Plans for up to 33% of Patients
-
1 in 3 Surveyed Physicians Say They Would Make a Different Treatment Choice If Medication Access Was Not a Factor
-
1 in 3 Surveyed Physicians Say They Would Make a Different Treatment Choice If Medication Access Was Not a Factor
-
Financial Times Ranks OptimizeRx Amongst Americas’ Fastest-Growing Companies for the Third Consecutive Year
-
Financial Times Ranks OptimizeRx Amongst Americas’ Fastest-Growing Companies for the Third Consecutive Year
-
Optimizerx Corporation (OPRX) Acquires EvinceMed
-
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform
-
OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform
-
OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022
-
OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022
-
OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum
-
OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum
-
Top 10 Pharma Deploys OptimizeRx’s Digital Access Solution to Streamline Patient Therapy Initiation Challenges
-
Top 10 Pharma Deploys OptimizeRx’s Digital Access Solution to Streamline Patient Therapy Initiation Challenges
-
OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance
-
OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance
-
OptimizeRx Sets Fourth Quarter and Full Year 2021 Conference Call for Thursday, February 24 at 4:30 p.m. ET
-
OptimizeRx Sets Fourth Quarter and Full Year 2021 Conference Call for Thursday, February 24 at 4:30 p.m. ET
-
OptimizeRx CEO, William Febbo, to Speak at the Bank of America Annual HCIT and Digital Health Conference
-
OptimizeRx CEO, William Febbo, to Speak at the Bank of America Annual HCIT and Digital Health Conference
-
OptimizeRx’s Mike Rousselle Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
-
OptimizeRx’s Mike Rousselle Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars
-
OptimizeRx to Participate in Upcoming February Investor Conferences
-
OptimizeRx to Participate in Upcoming February Investor Conferences
-
OptimizeRx’s AI-Driven Therapy Initiation and Persistence Platform Wins 2022 BIG Innovation Award
-
OptimizeRx’s AI-Driven Therapy Initiation and Persistence Platform Wins 2022 BIG Innovation Award
-
OptimizeRx to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022
-
OptimizeRx to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022
-
OptimizeRx’s Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360
-
OptimizeRx’s Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360
-
OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes
-
OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes
-
OptimizeRx Survey Addresses Treatment Selection, Discontinuation and Switching in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer – an Indication with Limited Patient Population
-
OptimizeRx Survey Addresses Treatment Selection, Discontinuation and Switching in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer – an Indication with Limited Patient Population
-
OptimizeRx Recognized by Digital Health Awards® Fall 2021 for TelaRep™ and its COVID-19 Text Message Campaign
-
OptimizeRx Recognized by Digital Health Awards® Fall 2021 for TelaRep™ and its COVID-19 Text Message Campaign
-
OptimizeRx Ranked Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™
-
OptimizeRx Ranked Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™
-
OptimizeRx to Participate at the Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
-
OptimizeRx to Participate at the Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference
-
OptimizeRx and Reuters Events™ Team Up with I AM ALS and RESOLVE: The National Infertility Association for Innovate4Outcomes™
-
OptimizeRx and Reuters Events™ Team Up with I AM ALS and RESOLVE: The National Infertility Association for Innovate4Outcomes™
-
OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased 53% in Continued Scale Up for Accelerated Growth
-
OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased 53% in Continued Scale Up for Accelerated Growth
-
Predictive Analytics Solutions Create New Opportunities for Life Sciences to Address Delayed Diagnosis and other Challenges in Multiple Sclerosis Treatment
-
Predictive Analytics Solutions Create New Opportunities for Life Sciences to Address Delayed Diagnosis and other Challenges in Multiple Sclerosis Treatment
-
OptimizeRx Sets Third Quarter Fiscal 2021 Conference Call for Tuesday, November 9 at 4:30 p.m. ET
-
OptimizeRx Sets Third Quarter Fiscal 2021 Conference Call for Tuesday, November 9 at 4:30 p.m. ET
-
OptimizeRx to Participate in Fireside Chat at the Credit Suisse 30th Annual Healthcare Conference
-
OptimizeRx to Participate in Fireside Chat at the Credit Suisse 30th Annual Healthcare Conference
